BioSpace News Archive

RTI Surgical Launches Fortilink-C IBF System, the First 3D Printed Polymer-based Interbody Device

RTI Surgical, Inc. today announced the commercial launch of Fortilink-C IBF System with TETRAfuse 3D Technology.

October 25, 2017

·

4 min read

Biotech Bay

Grant of Share Options to Directors, PDMRs and Employees and Grant of Restricted Stock Units to Summit Therapeutics’ Non-Executive Directors

The Company has also made a grant of restricted stock units (‘RSUs’) to the Non-Executive Directors under the Company’s 2017 Remuneration Policy.

October 25, 2017

·

9 min read

Summit Therapeutics: Grant of Share Options

Grant of share options to directors, PDMRs and employees and grant of restricted stock units to non-executive directors.

October 25, 2017

·

9 min read

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People With Type 2 Diabetes

Data from the study demonstrated significant cost avoidance to the healthcare system when used during a therapy change or when used at least twice per year.

October 25, 2017

·

4 min read

Pharm Country

BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

First to market alliance increases precision and specificity while reducing cost .

October 25, 2017

·

5 min read

Policy

NW Bio Reports Favorable Results and Progress in Resolving Lawsuits

NW Bio is pleased to report meaningful progress in resolving four lawsuits that were brought against it as reported in the Company’s periodic filings.

October 25, 2017

·

6 min read

Policy

Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA

The FDA has requested extra time to review its post-approval drug manufacturing submission that was filed with the FDA September 28, 2017.

October 25, 2017

·

3 min read

Pharm Country

Tyme Identifies Potential Method and Biomarker for Converting Malignant Tumors to Inert Calcified Mass

During clinical evaluation of Tyme’s lead candidate, it was observed that subsequent to SM-88 therapy some lytic bone lesions converted to benign sclerotic bone.

October 25, 2017

·

5 min read

Business

IGC to Distribute its Formulations in Germany in Early 2018

India Globalization Capital has entered into a Memorandum of Understandingwith MediCann Handels GmbH.

October 25, 2017

·

1 min read

Quotient Scores $40M and Eyes an Additional $49M

Quotient will use the cash to fund the ongoing development and commercial scale up and, if approved, commercialization of MosaiQ.

October 25, 2017

·

3 min read